99mTc-Sestamibi Scintigraphy Used to Evaluate Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Quantitative Analysis

Oncology Letters - Greece
doi 10.3892/ol_00000067
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

P53 Mutation Analysis to Predict Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer

2003English

Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer

Genetic Testing and Molecular Biomarkers
MedicineGenetics
2012English

Quantitative Ultrasound Evaluation of Tumor Cell Death Response in Locally Advanced Breast Cancer Patients Receiving Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2013English

Prolonged Neoadjuvant Chemotherapy With GM‐CSF in Locally Advanced Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1999English

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Prediction of Response to Preoperative Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Using Multicenter CT-Based Radiomic Analysis

Frontiers in Oncology
Cancer ResearchOncology
2020English

Size of Cervical Lesion in Locally Advanced Carcinoma Cervix and Response to Neoadjuvant Chemotherapy

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2019English

Cost-Effectiveness of 99mTc-Sestamibi in Predicting Response to Chemotherapy in Patients With Lung Cancer: Systematic Review and Meta-Analysis

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Osteopontin and Vasculogenic Mimicry Formation Are Associated With Response to Neoadjuvant Chemotherapy in Advanced Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy